Search

Your search keyword '"Darifenacin -- Product development"' showing total 2 results

Search Constraints

Start Over You searched for: Descriptor "Darifenacin -- Product development" Remove constraint Descriptor: "Darifenacin -- Product development" Topic business Remove constraint Topic: business
2 results on '"Darifenacin -- Product development"'

Search Results

1. Overactive Bladder Pipeline Drugs Analysis Report, 2023: FDA Approvals, Clinical Trials, Therapies by DelveInsight | Bayer, Taiho Pharmaceutical, Astellas Pharma Inc, Kyorin Pharmaceutical, Novartis

2. Overactive Bladder Pipeline Shows Rapid Advancements in the Clinical Trials: A Review by DelveInsight

Catalog

Books, media, physical & digital resources